NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,170 filers reported holding NOVARTIS A G in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $11,508,138 | +14.6% | 112,980 | +13.6% | 0.40% | +8.6% |
Q2 2023 | $10,039,632 | +7.9% | 99,491 | -1.6% | 0.37% | -1.3% |
Q1 2023 | $9,301,472 | -1.2% | 101,103 | -2.6% | 0.38% | -25.9% |
Q4 2022 | $9,416,149 | +76.3% | 103,794 | +47.7% | 0.51% | +40.2% |
Q3 2022 | $5,341,000 | -22.8% | 70,273 | -14.2% | 0.36% | -24.7% |
Q2 2022 | $6,922,000 | +2.1% | 81,885 | +5.9% | 0.48% | +3.0% |
Q1 2022 | $6,782,000 | +92.5% | 77,287 | +91.9% | 0.47% | +72.1% |
Q4 2021 | $3,523,000 | +17.3% | 40,279 | +9.7% | 0.27% | -11.4% |
Q3 2021 | $3,003,000 | +37.9% | 36,715 | +53.8% | 0.31% | +16.3% |
Q2 2021 | $2,177,000 | +127.5% | 23,865 | +113.3% | 0.26% | +54.4% |
Q1 2021 | $957,000 | +12.2% | 11,190 | +23.9% | 0.17% | -24.0% |
Q4 2020 | $853,000 | +90.8% | 9,028 | +75.7% | 0.22% | +31.6% |
Q3 2020 | $447,000 | -4.5% | 5,138 | -4.1% | 0.17% | -35.7% |
Q2 2020 | $468,000 | +103.5% | 5,359 | +91.8% | 0.27% | +38.5% |
Q1 2020 | $230,000 | – | 2,794 | – | 0.19% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Newman Dignan & Sheerar, Inc. | 3,739 | $353,074,000 | 56.77% |
Susquehanna International Securities, Ltd. | 118,837 | $11,222,000 | 8.15% |
MANAGED ASSET PORTFOLIOS, LLC | 336,762 | $31,800,000 | 5.59% |
Martin Investment Management, LLC | 169,019 | $15,960,000 | 5.10% |
SCHARF INVESTMENTS, LLC | 1,197,539 | $113,083,000 | 4.26% |
GARLAND CAPITAL MANAGEMENT INC | 50,705 | $4,788,000 | 4.06% |
Mawer Investment Management Ltd. | 6,625,594 | $625,655,000 | 3.69% |
SPHERA FUNDS MANAGEMENT LTD. | 429,000 | $40,510,000 | 3.60% |
First Fiduciary Investment Counsel, Inc. | 196,693 | $18,574,000 | 3.48% |
PROFESSIONAL ADVISORY SERVICES INC | 227,971 | $21,527,000 | 3.46% |